Bacteriological cultures on admission of the burn patient: To do or not to do, that's the question

Burns : Journal of the International Society for Burn Injuries
J DokterH Boxma

Abstract

In many burn centers, routine bacteriological swabs are taken from the nose, throat, perineum, and the burn wound on admission, to check for the presence of microorganisms that require specific measures in terms of isolation or initial treatment. According to the Dutch policy of "search and destroy," for example, patients infected by multiresistant bacteria have to be strictly isolated, and patients colonized with β-hemolytic Streptococcus pyogenes must receive antibiotic therapy to prevent failed primary closure or loss of skin grafts. In this respect, the role of bacteria cultured on admission in later infectious complications is investigated. The aim of this study is to assess systematic initial bacteriological surveillance, based on an extensive Dutch data collection. A total of 3271 patients primarily admitted to the Rotterdam Burn Centre between January 1987 and August 2010 with complete bacteriological swabs from nose, throat, perineum, and the burn wounds were included. For this study, microbiological surveillance was aimed at identifying resistant microorganisms such as methicillin-resistant Staphylococcus aureus (MRSA), multiresistant Acinetobacter, and multiresistant Pseudomonas, as well as Lancefield A β-hemolytic s...Continue Reading

References

Sep 1, 1985·The Journal of Hospital Infection·J C Lawrence
Jan 1, 1981·Antonie van Leeuwenhoek·W D HendriksP Kooy
Dec 1, 1995·Burns : Journal of the International Society for Burn Injuries·H Vindenes, R Bjerknes
Dec 25, 2003·Burns : Journal of the International Society for Burn Injuries·Edward E TredgetSarvesh Logsetty
May 18, 2004·Burns : Journal of the International Society for Burn Injuries·Serpil ErolMehmet Parlak
Oct 12, 2004·Burns : Journal of the International Society for Burn Injuries·Ulku AltoparlakAyten Kadanali
Apr 15, 2006·Clinical Microbiology Reviews·Deirdre ChurchRobert Lindsay
Jun 10, 2008·Burns : Journal of the International Society for Burn Injuries·G C BloemsmaI M M H Oen
Oct 23, 2010·Burns : Journal of the International Society for Burn Injuries·Patrick MaharJason Wasiak
Mar 11, 2011·Burns : Journal of the International Society for Burn Injuries·Ezzatollah RezaeiHassan Aliakbarian
Mar 23, 2011·Journal of Burn Care & Research : Official Publication of the American Burn Association·Meghann L KaiserMarianne E Cinat
Nov 2, 2011·Burns : Journal of the International Society for Burn Injuries·Nele BrusselaersStijn Blot
Jan 1, 2013·Clinical Medicine Insights. Gastroenterology·Asit Ranjan Ghosh

❮ Previous
Next ❯

Citations

Dec 16, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Bayless E DrumPranavi V Sreeramoju
Jul 21, 2017·Expert Review of Anti-infective Therapy·Julie GagnaireElisabeth Botelho-Nevers
Jul 30, 2019·Expert Review of Anti-infective Therapy·Roohi VinaikMarc G Jeschke
Jul 30, 2020·The Cochrane Database of Systematic Reviews·Cornelis J HoogewerfMargriet E Van Baar
Aug 27, 2019·Burns : Journal of the International Society for Burn Injuries·Harpreet Pangli, Anthony Papp
Feb 16, 2021·Applied Microbiology and Biotechnology·Bouke BoekemaEsther Middelkoop
Feb 25, 2021·Journal of Burn Care & Research : Official Publication of the American Burn Association·Zhao ChenXiaolong Liu
Aug 31, 2021·Burns and Trauma·Kenji Hayashida, Sho Yamakawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.